Cargando…
Potential of Membranes Surrounding the Fetus as Immunoprotective Cell-Carriers for Allogeneic Transplantations
Membranes surrounding the fetus play a crucial role in providing a physical and immunological barrier between a semiallogeneic fetus and mother during pregnancy. In this study, we tested whether cotransplantation of fetal membranes (FMs) and allogeneic donor cells would improve the retention and fun...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6553624/ https://www.ncbi.nlm.nih.gov/pubmed/31321294 http://dx.doi.org/10.1097/TXD.0000000000000901 |
_version_ | 1783424845247152128 |
---|---|
author | Togarrati, Padma Priya Dinglasan, Nuntana Yee, Elizabeth Heitman, John W. Jackman, Rachael P. Geisberg, Mark Norris, Philip J. Bárcena, Alicia Muench, Marcus O. |
author_facet | Togarrati, Padma Priya Dinglasan, Nuntana Yee, Elizabeth Heitman, John W. Jackman, Rachael P. Geisberg, Mark Norris, Philip J. Bárcena, Alicia Muench, Marcus O. |
author_sort | Togarrati, Padma Priya |
collection | PubMed |
description | Membranes surrounding the fetus play a crucial role in providing a physical and immunological barrier between a semiallogeneic fetus and mother during pregnancy. In this study, we tested whether cotransplantation of fetal membranes (FMs) and allogeneic donor cells would improve the retention and function of allografts in mice. METHODS. Intact and enzyme-digested membranes obtained from E18-E19 pregnant mice were subcutaneously cotransplanted with 10F7MN hybridoma cells that are of BALB/cByJ (Balb) origin and secrete anti-human CD235a antibody. Cells were transplanted into C57BL/6J (B6, allogeneic), Balb (syngeneic), and FVB/NJ (third-party) mice. Serum was collected after 1 and 3 weeks of cell transplantation and tested using flow cytometry for the presence of anti-human CD235a antibody. Immunosuppressive functions of membranes were further investigated by analyzing the cytokine profile of supernatants collected from allo-reactive mixed lymphocyte reactions (MLRs) using a multiplex cytokine assay. RESULTS. B6 mice transplanted with 10F7MN cells along with membranes syngeneic to the host had significantly higher levels of CD235a antibody when compared to B6 mice that received cells without membranes, allogenic membranes, or third-party membranes. Syngeneic membranes significantly inhibited T-cell proliferation in the presence of allogeneic stimuli and suppressed the release of Th1-cytokines such as IFNγ, TNFα, and IL-2 in MLRs. Additionally, increases in the levels of Th2-cytokines were found in MLRs containing membrane-derived cells. CONCLUSIONS. Our study highlights the potential use of syngeneic FMs to act as potent cell-carriers that could improve graft retention as well as graft-specific immunoprotection during allograft transplantation. |
format | Online Article Text |
id | pubmed-6553624 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Wolters Kluwer Health |
record_format | MEDLINE/PubMed |
spelling | pubmed-65536242019-07-18 Potential of Membranes Surrounding the Fetus as Immunoprotective Cell-Carriers for Allogeneic Transplantations Togarrati, Padma Priya Dinglasan, Nuntana Yee, Elizabeth Heitman, John W. Jackman, Rachael P. Geisberg, Mark Norris, Philip J. Bárcena, Alicia Muench, Marcus O. Transplant Direct Cell Therapy Membranes surrounding the fetus play a crucial role in providing a physical and immunological barrier between a semiallogeneic fetus and mother during pregnancy. In this study, we tested whether cotransplantation of fetal membranes (FMs) and allogeneic donor cells would improve the retention and function of allografts in mice. METHODS. Intact and enzyme-digested membranes obtained from E18-E19 pregnant mice were subcutaneously cotransplanted with 10F7MN hybridoma cells that are of BALB/cByJ (Balb) origin and secrete anti-human CD235a antibody. Cells were transplanted into C57BL/6J (B6, allogeneic), Balb (syngeneic), and FVB/NJ (third-party) mice. Serum was collected after 1 and 3 weeks of cell transplantation and tested using flow cytometry for the presence of anti-human CD235a antibody. Immunosuppressive functions of membranes were further investigated by analyzing the cytokine profile of supernatants collected from allo-reactive mixed lymphocyte reactions (MLRs) using a multiplex cytokine assay. RESULTS. B6 mice transplanted with 10F7MN cells along with membranes syngeneic to the host had significantly higher levels of CD235a antibody when compared to B6 mice that received cells without membranes, allogenic membranes, or third-party membranes. Syngeneic membranes significantly inhibited T-cell proliferation in the presence of allogeneic stimuli and suppressed the release of Th1-cytokines such as IFNγ, TNFα, and IL-2 in MLRs. Additionally, increases in the levels of Th2-cytokines were found in MLRs containing membrane-derived cells. CONCLUSIONS. Our study highlights the potential use of syngeneic FMs to act as potent cell-carriers that could improve graft retention as well as graft-specific immunoprotection during allograft transplantation. Wolters Kluwer Health 2019-05-29 /pmc/articles/PMC6553624/ /pubmed/31321294 http://dx.doi.org/10.1097/TXD.0000000000000901 Text en Copyright © 2019 The Author(s). Transplantation Direct. Published by Wolters Kluwer Health, Inc. This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND) (http://creativecommons.org/licenses/by-nc-nd/4.0/) , where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. |
spellingShingle | Cell Therapy Togarrati, Padma Priya Dinglasan, Nuntana Yee, Elizabeth Heitman, John W. Jackman, Rachael P. Geisberg, Mark Norris, Philip J. Bárcena, Alicia Muench, Marcus O. Potential of Membranes Surrounding the Fetus as Immunoprotective Cell-Carriers for Allogeneic Transplantations |
title | Potential of Membranes Surrounding the Fetus as Immunoprotective Cell-Carriers for Allogeneic Transplantations |
title_full | Potential of Membranes Surrounding the Fetus as Immunoprotective Cell-Carriers for Allogeneic Transplantations |
title_fullStr | Potential of Membranes Surrounding the Fetus as Immunoprotective Cell-Carriers for Allogeneic Transplantations |
title_full_unstemmed | Potential of Membranes Surrounding the Fetus as Immunoprotective Cell-Carriers for Allogeneic Transplantations |
title_short | Potential of Membranes Surrounding the Fetus as Immunoprotective Cell-Carriers for Allogeneic Transplantations |
title_sort | potential of membranes surrounding the fetus as immunoprotective cell-carriers for allogeneic transplantations |
topic | Cell Therapy |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6553624/ https://www.ncbi.nlm.nih.gov/pubmed/31321294 http://dx.doi.org/10.1097/TXD.0000000000000901 |
work_keys_str_mv | AT togarratipadmapriya potentialofmembranessurroundingthefetusasimmunoprotectivecellcarriersforallogeneictransplantations AT dinglasannuntana potentialofmembranessurroundingthefetusasimmunoprotectivecellcarriersforallogeneictransplantations AT yeeelizabeth potentialofmembranessurroundingthefetusasimmunoprotectivecellcarriersforallogeneictransplantations AT heitmanjohnw potentialofmembranessurroundingthefetusasimmunoprotectivecellcarriersforallogeneictransplantations AT jackmanrachaelp potentialofmembranessurroundingthefetusasimmunoprotectivecellcarriersforallogeneictransplantations AT geisbergmark potentialofmembranessurroundingthefetusasimmunoprotectivecellcarriersforallogeneictransplantations AT norrisphilipj potentialofmembranessurroundingthefetusasimmunoprotectivecellcarriersforallogeneictransplantations AT barcenaalicia potentialofmembranessurroundingthefetusasimmunoprotectivecellcarriersforallogeneictransplantations AT muenchmarcuso potentialofmembranessurroundingthefetusasimmunoprotectivecellcarriersforallogeneictransplantations |